MAP, a leading global health organization that provides medicine, health supplies, and medical devices to those in need around the world, recently announced Meghan Lucido as Director of their domestic medicine program, MAP USA.

MAP International, a nonprofit global health organization based in Brunswick, Georgia, is mobilizing to send disaster relief to Jamaica and other hard-hit areas in the wake of Hurricane Melissa.

MAP International, a global health organization that delivers medicine, health supplies, and medical devices to those in need worldwide, unveiled a new logo and brand strategy. The change reflects the organization’s commitment to excellence in a rapidly evolving humanitarian and global health field.

MAP International is proud to partner with Project Vietnam Foundation and funding organization Astellas Pharma Inc., to implement a public health initiative to help increase prostate cancer awareness and promote early detection in Vietnam.

Brunswick, GA, September 1, 2025 – MAP International, one of the largest charities in the nation, which supplies over $1 billion in donated medication and healthcare supplies domestically and across the globe, is celebrating the addition of Justin Ward as Chief Operations and Information Officer (COO/CIO). Ward is a seasoned leader with over 20 years of experience in data analytics, business intelligence, supply chain logistics and cloud platforms.

MAP International, a leading nonprofit organization in the global health arena, recently reached a historic milestone, acquiring over $1 billion in donated medicine and health supplies and distributing $1 billion worth of medicine and health supplies across the globe this year.

Inspired by a shared commitment to bring better health to families by connecting patients all over the world with the medicine they need most, Fosun Pharma USA Inc. and MAP International have launched a global collaboration to grow access to essential pain relief in underserved communities.

Orphalan SA, a global pharmaceutical company focused on rare diseases, is partnering with MAP International and the Wilson Disease Association (WDA) to provide Cuvrior® (trientine tetrahydrochloride) to patients with Wilson Disease in developing countries.

ChildFund, a child-development agency, and MAP International, Medicine for All People, have joined forces on an impactful initiative in Sierra Leone.